InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,305.09
(
0.01%
)
US TECH 100
18,384.80
(
0.36%
)
Dow Jones
38,836.22
(
-0.60%
)
Brent Oil
83.88
(
1.25%
)
Bitcoin
67,732.57
(
-2.39%
)

Replies to post #201662 on Biotech Values

Replies to #201662 on Biotech Values

DewDiligence

05/30/16 11:00 AM

#201667 RE: jbog #201662

GILD—You seem surprised. This is an everyday occurrence in the pharma field.

Not surprised at all. The consequential question in all this is whether GILD’s ancillary patents on TAF (and its various single-tablet combination regimens) will stand up to challenge.